Bispecific agonist boosts anti-tumour T cells via GITR

被引:0
|
作者
Alexandra Flemming
机构
[1] Nature Reviews Immunology,
来源
Nature Reviews Immunology | 2022年 / 22卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
A bispecific molecule consisting of a PD1 antibody fused to a multimeric ligand for the costimulatory molecule GITR shows promising results in preclinical studies of solid tumours.
引用
收藏
页码:208 / 208
相关论文
共 50 条
  • [41] Effect of spermine synthase on the sensitivity of cells to anti-tumour agents
    Ikeguchi, Y
    Mackintosh, CA
    McCloskey, DE
    Pegg, AE
    BIOCHEMICAL JOURNAL, 2003, 373 : 885 - 892
  • [42] NK Cells in the Lymph Nodes and Their Role in Anti-Tumour Immunity
    Graham, Lara V.
    Khakoo, Salim I.
    Blunt, Matthew D.
    BIOMEDICINES, 2024, 12 (08)
  • [43] Apatinib exerts anti-tumour effects on ovarian cancer cells
    Ding, Jing
    Cheng, Xiao-yan
    Liu, Shuang
    Ji, Hong-ying
    Lin, Mu
    Ma, Rong
    Meng, Fan-ling
    GYNECOLOGIC ONCOLOGY, 2019, 153 (01) : 165 - 174
  • [44] Mesenchymal stromal cells as regulators of anti-tumour immune response
    Poggi, Alessandro
    Zocchi, M. R.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2015, 141 : 139 - 142
  • [45] ISOLATION OF A SUBPOPULATION OF ADHERENT PERITONEAL CELLS WITH ANTI-TUMOUR ACTIVITY
    NATHAN, CF
    HILL, VM
    TERRY, WD
    NATURE, 1976, 260 (5547) : 146 - 148
  • [46] EFFECT OF ANTI-TUMOUR AGENTS ON NON-DIVIDING CELLS
    BERENBAUM, MC
    CALLEY, M
    NATURE, 1962, 196 (4855) : 656 - &
  • [47] Agonist anti-GITR monoclonal antibody targets both regulatory and effector T cells to induce tumor immunity
    Cohen, Adam
    Schaer, David
    Merghoub, Taha
    Liu, Cailian
    Li, Yanyun
    Hirschhorn-Cymmerman, Daniel
    Diab, Adi
    Rizzuto, Gabrielle
    Kim, Soo
    Perales, Miguel
    Wolchok, Jedd
    Houghton, Alan
    CANCER RESEARCH, 2009, 69
  • [48] Anti-Apoptotic c-FLIP Reduces the Anti-Tumour Activity of Chimeric Antigen Receptor T Cells
    Tan, Grace Min Yi
    Poudel, Aarati
    Rad, Seyed Mohammad Ali Hosseini
    McLellan, Alexander Donald
    CANCERS, 2022, 14 (19)
  • [49] Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells
    Alistair L. J. Symonds
    Tizong Miao
    Zabreen Busharat
    Suling Li
    Ping Wang
    Cancer Immunology, Immunotherapy, 2023, 72 : 1139 - 1151
  • [50] Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8+T cells
    Symonds, Alistair L. J.
    Miao, Tizong
    Busharat, Zabreen
    Li, Suling
    Wang, Ping
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (05) : 1139 - 1151